|
1
|
Sénéchal C, Cottereau E, de Pauw A, Elan
C, Dagousset I, Fourchotte V, Gauthier-Villars M, Lae M,
Stoppa-Lyonnet D and Buecher B: Environmental and genetic risk
factors for endometrial carcinoma. Bull Cancer. 102:256–269.
2015.In French. View Article : Google Scholar
|
|
2
|
Ashton KA, Proietto A, Otton G, Symonds I,
McEvoy M, Attia J, Gilbert M, Hamann U and Scott RJ: Polymorphisms
in genes of the steroid hormone biosynthesis and metabolism
pathways and endometrial cancer risk. Cancer Epidemiol. 34:328–337.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Lin X, Zhu H, Zhang Z and Yang B:
Genetic variation of the CYP17 and susceptibility to endometrial
cancer: A meta-analysis. Mol Biol Rep. 40:5085–5091. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collaborative Group on Epidemiological
Studies on Endometrial Cancer: Endometrial cancer and oral
contraceptives: An individual participant meta-analysis of 27 276
women with endometrial cancer from 36 epidemiological studies.
Lancet Oncol. 16:1061–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trabert B, Wentzensen N, Yang HP, Sherman
ME, Hollenbeck AR, Park Y and Brinton LA: Is estrogen plus
progestin menopausal hormone therapy safe with respect to
endometrial cancer risk? Int J Cancer. 132:417–426. 2013.
View Article : Google Scholar
|
|
6
|
Brinton LA, Westhoff CL, Scoccia B, Lamb
EJ, Trabert B, Niwa S and Moghissi KS: Fertility drugs and
endometrial cancer risk: Results from an extended follow-up of a
large infertility cohort. Hum Reprod. 28:2813–2821. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ong M, Carreira S, Goodall J, Mateo J,
Figueiredo I, Rodrigues DN, Perkins G, Seed G, Yap TA, Attard G, et
al: Validation and utilisation of high-coverage next-generation
sequencing to deliver the pharmacological audit trail. Br J Cancer.
111:828–836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
André F, Bachelot T, Commo F, Campone M,
Arnedos M, Dieras V, Lacroix-Triki M, Lacroix L, Cohen P, Gentien
D, et al: Comparative genomic hybridisation array and DNA
sequencing to direct treatment of metastatic breast cancer: A
multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol.
15:267–274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bell D, Berchuck A, Birrer M, Chien J,
Cramer DW, Dao F, Dhir R, DiSaia P, Gabra H, Glenn P, et al Cancer
Genome Atlas Research Network: Integrated genomic analyses of
ovarian carcinoma. Nature. 474:609–615. 2011. View Article : Google Scholar
|
|
11
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kandoth C, Schultz N, Cherniack AD, Akbani
R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al
Cancer Genome Atlas Research Network: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beadling C, Neff TL, Heinrich MC, Rhodes
K, Thornton M, Leamon J, Andersen M and Corless CL: Combining
highly multiplexed PCR with semiconductor-based sequencing for
rapid cancer genotyping. J Mol Diagn. 15:171–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grasso C, Butler T, Rhodes K, Quist M,
Neff TL, Moore S, Tomlins SA, Reinig E, Beadling C, Andersen M, et
al: Assessing copy number alterations in targeted, amplicon-based
next-generation sequencing data. J Mol Diagn. 17:53–63. 2015.
View Article : Google Scholar
|
|
15
|
Zheng Z, Liebers M, Zhelyazkova B, Cao Y,
Panditi D, Lynch KD, Chen J, Robinson HE, Shim HS, Chmielecki J, et
al: Anchored multiplex PCR for targeted next-generation sequencing.
Nat Med. 20:1479–1484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samorodnitsky E, Datta J, Jewell BM,
Hagopian R, Miya J, Wing MR, Damodaran S, Lippus JM, Reeser JW,
Bhatt D, et al: Comparison of custom capture for targeted
next-generation DNA sequencing. J Mol Diagn. 17:64–75. 2015.
View Article : Google Scholar :
|
|
17
|
Drmanac R, Peters BA, Church GM, Reid CA
and Xu X: Accurate whole genome sequencing as the ultimate genetic
test. Clin Chem. 61:305–306. 2015. View Article : Google Scholar
|
|
18
|
Park JY, Clark P, Londin E, Sponziello M,
Kricka LJ and Fortina P: Clinical exome performance for reporting
secondary genetic findings. Clin Chem. 61:213–220. 2015. View Article : Google Scholar :
|
|
19
|
Liang H, Cheung LW, Li J, Ju Z, Yu S,
Stemke-Hale K, Dogruluk T, Lu Y, Liu X, Gu C, et al: Whole-exome
sequencing combined with functional genomics reveals novel
candidate driver cancer genes in endometrial cancer. Genome Res.
22:2120–2129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Langmead B, Trapnell C, Pop M and Salzberg
SL: Ultrafast and memory-efficient alignment of short DNA sequences
to the human genome. Genome Biol. 10:R252009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M, et al: The Genome Analysis Toolkit: A MapReduce framework for
analyzing next-generation DNA sequencing data. Genome Res.
20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sherry ST, Ward MH, Kholodov M, Baker J,
Phan L, Smigielski EM and Sirotkin K: dbSNP: The NCBI database of
genetic variation. Nucleic Acids Res. 29:308–311. 2001. View Article : Google Scholar :
|
|
23
|
Landrum MJ, Lee JM, Riley GR, Jang W,
Rubinstein WS, Church DM and Maglott DR: ClinVar: Public archive of
relationships among sequence variation and human phenotype. Nucleic
Acids Res. 42(D1): D980–D985. 2014. View Article : Google Scholar :
|
|
24
|
Forbes SA, Beare D, Gunasekaran P, Leung
K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, et
al: COSMIC: Exploring the world's knowledge of somatic mutations in
human cancer. Nucleic Acids Res. 43(D1): D805–D811. 2015.
View Article : Google Scholar :
|
|
25
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R and Larsson E:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBio-Portal. Sci Signal. 6:pl12013. View Article : Google Scholar
|
|
26
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar P, Henikoff S and Ng PC: Predicting
the effects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat Protoc. 4:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hua X, Xu H, Yang Y, Zhu J, Liu P and Lu
Y: DrGaP: A powerful tool for identifying driver genes and pathways
in cancer sequencing studies. Am J Hum Genet. 93:439–451. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang YS, Huang HD, Yeh KT and Chang JG:
Genetic alterations in endometrial cancer by targeted
next-generation sequencing. Exp Mol Pathol. 100:8–12. 2016.
View Article : Google Scholar
|
|
30
|
Hovelson DH, McDaniel AS, Cani AK, Johnson
B, Rhodes K, Williams PD, Bandla S, Bien G, Choppa P, Hyland F, et
al: Development and validation of a scalable next-generation
sequencing system for assessing relevant somatic variants in solid
tumors. Neoplasia. 17:385–399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kwiatkowski DJ, Choueiri TK, Fay AP, Rini
BI, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L,
Agarwal N, et al: Mutations in TSC1, TSC2, and MTOR are associated
with response to rapalogs in patients with metastatic renal cell
carcinoma. Clin Cancer Res. 22:2445–2452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choschzick M, Tabibzada AM, Gieseking F,
Woelber L, Jaenicke F, Sauter G and Simon R: BIRC2 amplification in
squamous cell carcinomas of the uterine cervix. Virchows Arch.
461:123–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma XY, Ma CX and Wang JH: Endometrial
carcinogenesis and molecular signaling pathways. Am J Mol Biol.
4:134–149. 2014. View Article : Google Scholar
|
|
34
|
Nam JY, Kim NK, Kim SC, Joung JG, Xi R,
Lee S, Park PJ and Park WY: Evaluation of somatic copy number
estimation tools for whole-exome sequencing data. Brief Bioinform.
17:185–192. 2016. View Article : Google Scholar
|
